Sutro Biopharma, Inc. · NASDAQ:STRO
Gerber Hans-Peter exercised options for 3,750 Sutro Biopharma, Inc. shares (Form 4)
Traded Sep 18, 2026 · Filed Sep 22, 2026
On Sep 18, 2026, Gerber Hans-Peter (CHIEF SCIENTIFIC OFFICER) exercised options for 3,750 Sutro Biopharma, Inc. shares, leaving 12,367 shares. Filed Sep 22, 2026 (Form 4).
- Options exercised
- 3,750 shares
- Holding after
- 12,367 shares
- Trading plan
- No
- Role
- CHIEF SCIENTIFIC OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 18, 2026 | Common Stock | Option exercise | 3,750 | 13,712 | Direct | |
| Sep 18, 2026 | Common Stock | Shares withheld for tax | 1,345 | US$15.34 | 12,367 | Direct |
Source
Related
- Sutro Biopharma, Inc.
- Gerber Hans-Peter
- Sutro Biopharma, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026
- Form 4 · Chow Gregory K. · Jun 2, 2026
- Schedule 13G · Srinivas Akkaraju · May 15, 2026